Rates of Congestion and CV Outcomes in Patients Hospitalized for Acute Heart Failure
Researchers examined if the rate of decongestion in acute heart failure is associated with cardiovascular outcomes and mortality.
Congestive Heart Failure
Mortality and Incidence of New-Onset Atrial Arrhythmias in Patients With COVID-19
Investigators examined in-hospital mortality in patients hospitalized with COVID-19 with new-onset atrial arrhythmias and history of atrial arrhythmias.
Empagliflozin Reduced Hospitalization Risk, Death in HFpEF
The phase 3 EMPEROR-Preserved trial included 5988 adult patients with heart failure with preserved ejection fraction, with and without diabetes.
Stroke and Systemic Embolism Risk Is Highest with HFpEF Among Heart Failure Types
Study authors assessed the risk of stroke and systemic embolism in patients with atrial fibrillation and heart failure according to HF types.
Medications for Enlarged Prostate Tied to Heart Failure Risk
Researchers assessed whether medications used for benign prostatic hyperplasia was associated with development of heart failure risk.
Rivaroxaban Is Noninferior to Warfarin for AF Patients With a Bioprosthetic Mitral Valve
Investigators examined the effects of rivaroxaban (20 mg once daily) vs dose-adjusted warfarin in patients with atrial fibrillation and a bioprosthetic mitral valve.
Ischemic Heart Disease, Heart Failure Mortality Vary Across VA Systems
Risk-standardized mortality rates for ischemic heart disease and heart failure vary considerably across Veterans Affairs Medical Centers.
Resistant Hypertension May Increase Sleep Apnea Risk
Patients with resistant hypertension had a modest increase in risk of developing sleep apnea compared to those with nonresistant hypertension.
- Loading...
Loading...
Loading... 
Loading...